Prevalence of chronic hepatitis E infection in immunosuppressed patients in Belgium.
INTRODUCTION: Hepatitis E virus (HEV) is now considered as the commonest cause of acute viral hepatitis in Western countries, especially genotype 3 and 4. In immunocompromised patients, chronic HEV have been described, leading in certain cases to cirrhosis, decompensation and death or liver transplantation. A recently published study from the UK based on a Markov cohort model suggests that routine screening for HEV in solid organ transplant (SOT) is very likely to be cost-effective, even more in patients with abnormal transaminases. No data are available on the real prevalence and incidence of... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | conferenceObject |
Erscheinungsdatum: | 2023 |
Verlag/Hrsg.: |
Universa Press
|
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26599358 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2078.1/274405 |
INTRODUCTION: Hepatitis E virus (HEV) is now considered as the commonest cause of acute viral hepatitis in Western countries, especially genotype 3 and 4. In immunocompromised patients, chronic HEV have been described, leading in certain cases to cirrhosis, decompensation and death or liver transplantation. A recently published study from the UK based on a Markov cohort model suggests that routine screening for HEV in solid organ transplant (SOT) is very likely to be cost-effective, even more in patients with abnormal transaminases. No data are available on the real prevalence and incidence of HEV chronic infections in this population in Belgium. [.]